Gleb Slobodin

3.6k total citations
141 papers, 2.3k citations indexed

About

Gleb Slobodin is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gleb Slobodin has authored 141 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Rheumatology, 35 papers in Immunology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gleb Slobodin's work include Spondyloarthritis Studies and Treatments (29 papers), Systemic Sclerosis and Related Diseases (20 papers) and Rheumatoid Arthritis Research and Therapies (19 papers). Gleb Slobodin is often cited by papers focused on Spondyloarthritis Studies and Treatments (29 papers), Systemic Sclerosis and Related Diseases (20 papers) and Rheumatoid Arthritis Research and Therapies (19 papers). Gleb Slobodin collaborates with scholars based in Israel, United States and Italy. Gleb Slobodin's co-authors include Itzhak Rosner, Michael Rozenbaum, Nina Boulman, Jochanan E. Naschitz, Elias Toubi, Aharon Kessel, Daniel Yeshurun, Doron Rimar, Eli Zuckerman and E. Zuckerman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and International Journal of Molecular Sciences.

In The Last Decade

Gleb Slobodin

133 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gleb Slobodin Israel 26 752 543 495 414 383 141 2.3k
Renqian Zhong China 23 651 0.9× 597 1.1× 431 0.9× 364 0.9× 240 0.6× 65 2.4k
Maria Giovanna Danieli Italy 28 642 0.9× 637 1.2× 497 1.0× 181 0.4× 339 0.9× 79 1.8k
Zaixing Yang China 22 822 1.1× 512 0.9× 459 0.9× 248 0.6× 281 0.7× 71 2.6k
Bao‐Dong Qin China 25 637 0.8× 494 0.9× 341 0.7× 124 0.3× 320 0.8× 71 3.1k
Luis J. Jara Mexico 37 2.0k 2.6× 442 0.8× 1.2k 2.4× 187 0.5× 515 1.3× 122 3.7k
Marilina Tampoia Italy 25 640 0.9× 516 1.0× 303 0.6× 101 0.2× 547 1.4× 80 1.8k
Shane M. Meehan United States 27 306 0.4× 277 0.5× 769 1.6× 176 0.4× 358 0.9× 57 3.4k
Jason Jungsik Song South Korea 27 921 1.2× 324 0.6× 468 0.9× 95 0.2× 199 0.5× 215 2.7k
Eun Ha Kang South Korea 28 1.1k 1.5× 689 1.3× 414 0.8× 68 0.2× 346 0.9× 127 2.6k
Meral Çalgünerı Türkiye 31 1.1k 1.4× 258 0.5× 558 1.1× 99 0.2× 346 0.9× 98 3.2k

Countries citing papers authored by Gleb Slobodin

Since Specialization
Citations

This map shows the geographic impact of Gleb Slobodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gleb Slobodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gleb Slobodin more than expected).

Fields of papers citing papers by Gleb Slobodin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gleb Slobodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gleb Slobodin. The network helps show where Gleb Slobodin may publish in the future.

Co-authorship network of co-authors of Gleb Slobodin

This figure shows the co-authorship network connecting the top 25 collaborators of Gleb Slobodin. A scholar is included among the top collaborators of Gleb Slobodin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gleb Slobodin. Gleb Slobodin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yaari, Shlomit, Lisa Kaly, Itzhak Rosner, et al.. (2025). Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in SSc: a real-world national cohort study. Lara D. Veeken. 65(2). 1 indexed citations
2.
Sabag, Adi D., et al.. (2025). Semaphorin3A Rewires CD4+ T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid Arthritis. International Journal of Molecular Sciences. 26(22). 11160–11160.
3.
Zisman, Devy, Amir Haddad, Tal Gazitt, et al.. (2024). Tofacitinib Regulates Endostatin via Effects on CD147 and Cathepsin S. International Journal of Molecular Sciences. 25(13). 7267–7267. 1 indexed citations
4.
Haddad, Amir, Tal Gazitt, Joy Feld, et al.. (2024). Soluble CD147 regulates endostatin via its effects on the activities of MMP-9 and secreted proteasome 20S. Frontiers in Immunology. 15. 1319939–1319939. 4 indexed citations
6.
Lidar, Merav, Yael Shinar, Haike Reznik‐Wolf, et al.. (2018). A high and equal prevalence of the Q703K variant in NLRP3 patients with autoinflammatory symptoms and ethnically matched controls.. PubMed. 35 Suppl 108(6). 82–85. 5 indexed citations
7.
Slobodin, Gleb, Doron Rimar, Nina Boulman, et al.. (2015). Craniocervical junction involvement in ankylosing spondylitis. European Spine Journal. 24(12). 2986–2990. 8 indexed citations
8.
Elias, Nizar, et al.. (2015). Recurrent Cough Syncope Due to Pertussis in an Adult: A Case Report and Review of the Literature. Journal of Medical Cases. 6(1). 33–35.
9.
Slobodin, Gleb, et al.. (2015). Increased aortic wall thickness for the diagnosis of aortitis: a computed tomography‐based study. International Journal of Rheumatic Diseases. 19(1). 82–86. 11 indexed citations
10.
Slobodin, Gleb, Doron Rimar, Nina Boulman, et al.. (2015). Entheseal involvement in systemic disorders. Clinical Rheumatology. 34(12). 2001–2010. 13 indexed citations
11.
Snir, Ayelet, Aharon Kessel, Tharwat Haj, et al.. (2011). Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.. PubMed. 29(4). 697–700. 41 indexed citations
12.
Zeina, Abdel‐Rauf, et al.. (2007). Isolated periaortitis: Clinical and imaging characteristics. SHILAP Revista de lepidopterología. 6 indexed citations
13.
Toubi, Elias, Aharon Kessel, Gleb Slobodin, et al.. (2006). Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 66(6). 818–820. 59 indexed citations
14.
Slobodin, Gleb. (2006). The emergency room in systemic rheumatic diseases. Emergency Medicine Journal. 23(9). 667–671. 9 indexed citations
15.
Yeshurun, Daniel, Gleb Slobodin, Dean Keren, & Nizar Elias. (2005). Statin escape phenomenon: Does it really exist?. European Journal of Internal Medicine. 16(3). 192–194. 4 indexed citations
16.
Groshar, David, Gleb Slobodin, & Eli Zuckerman. (2002). Quantitation of liver and spleen uptake of (99m)Tc-phytate colloid using SPECT: detection of liver cirrhosis.. PubMed. 43(3). 312–7. 23 indexed citations
17.
Toubi, Elias, Aharon Kessel, Lee E. Goldstein, et al.. (2001). Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity. Journal of Hepatology. 35(6). 774–780. 50 indexed citations
18.
Slobodin, Gleb, Itzhak Rosner, Michael Rozenbaum, et al.. (2000). Systemic sclerosis sine scleroderma: Comment on the article by Poormoghim et al. Arthritis & Rheumatism. 43(11). 2618–2618. 2 indexed citations
19.
Zuckerman, E., Dean Keren, Michael Rozenbaum, et al.. (2000). Hepatitis C virus-related arthritis: characteristics and response to therapy with interferon alpha.. PubMed. 18(5). 579–84. 66 indexed citations
20.
Naschitz, Jochanan E., Gleb Slobodin, Roger Lewis, E. Zuckerman, & Daniel Yeshurun. (2000). Heart diseases affecting the liver and liver diseases affecting the heart. American Heart Journal. 140(1). 111–120. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026